Hormonal management of migraine at menopause

Menopause International

Volumn 15, Issue 2, 2009, Pages 82-86

  Nappi, Rossella E ^a   Sances, Grazia ^a,b   Detaddei, Silvia ^a,b   Ornati, Alessandra ^a   Chiovato, Luca ^a   Polatti, Franco ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Climacteric; estrogen; headache; progestin; tibolone

Indexed keywords

ANALGESIC AGENT; ANTIMIGRAINE AGENT; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; FLUOXETINE; GABAPENTIN; GESTAGEN; MEDROXYPROGESTERONE; PAROXETINE; PLACEBO; PROGESTERONE; TIBOLONE; VENLAFAXINE;

ANALGESIC AGENT ABUSE; CLIMACTERIUM; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG WITHDRAWAL; ENDOCRINE DISEASE; HEADACHE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MENOPAUSAL SYNDROME; MENOPAUSE; MIGRAINE; MIGRAINE WITH AURA; NEUROENDOCRINE SYSTEM; PREVALENCE; QUALITY OF LIFE; REVIEW; UNSPECIFIED SIDE EFFECT;

ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HEALTH STATUS; HUMANS; MENOPAUSE; MIDDLE AGED; MIGRAINE DISORDERS; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 67649982794     PISSN: 17540453     EISSN: 17540461     Source Type: Journal    
DOI: 10.1258/mi.2009.009022     Document Type: Review

References (58)

1. Karwautz A, Wöber-Bingöl C, Wöber C. Freud and migraine: the beginning of a psychodynamically oriented view of headache a hundred years ago. Cephalalgia 1996; 16: 22–26
2. Magos A, Studd J. Effects of the menstrual cycle on medical disorders. Br J Hosp Med 1985; 33: 68–77
3. Silberstein SD. The role of sex hormones in headache. Neurology 1992; 42: 37–42
4. Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005; 45: S3–13
5. Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. Eur J Neurol 2006; 13: 333–45
6. Lipton RB, Stewart WF. Migraine in the United States: a review of epidemiology and health care use. Neurology 1993; 43: S6–10
7. Rasmussen BK. Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993; 53: 65–72
8. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur J Epidemiol 2005; 20: 243–249
9. Lipton RB, Bigal ME, Diamond M,, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68: 343–349
10. Mortimer MJ, Kay J, Jaron A. Childhood migraine in general practice: clinical features and characteristics. Cephalalgia 1992; 12: 238–43
11. Rasmussen BK. Epidemiology of headache. Cephalalgia 1995; 15: 45–68
12. Welch KM, Darnley D, Simkins RT. The role of estrogen in migraine: a review and hypothesis. Cephalalgia 1984; 4: 227–36
13. Silberstein SD. Sex hormones and headache. Rev Neurol (Paris) 2000; 156: 4S30–4S41
14. MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006; 67: 2154–8
15. Brandes JL. The influence of estrogen on migraine: a systematic review. JAMA 2006; 295: 1824–30
16. Granella F, Sances G, Allais G,, et al. Characteristics of menstrual and non-menstrual attacks in women with menstrually-related migraine. Cephalagia 2004; 24: 707–16
17. Magos AL, Zilkha KJ, Studd JW. Treatment of menstrual migraine by oestradiol implants. J Neurol Neurosurg Psychiatry 1983; 46: 1044–6
18. Nappi RE, Sances G, Brundu B,, et al. Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus. Neuroendocrinology 2003; 78: 52–60
19. Nappi RE, Sances G, Brundu B,, et al. Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval. Hum Reprod 2005; 20: 3423–8
20. MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol 2004; 3: 354–61
21. Lay CL, Broner SW. Migraine in women. Neurol Clin 2009; 27: 503–11
22. Nappi RE, Veneroni F, Chiapparini I,, et al. Gonadal hormones and migraine: a tight bondage within the female brain. Semin Headache Manage 1999; 4: 11–15
23. Solomon GD, Kunkel RS Jr, Frame J. Demographics of headache in elderly patients. Headache 1990; 30: 273–276
24. Avis NE, McKinlay SM. A longitudinal analysis of women's attitudes toward the menopause: results from the Massachusetts Women's Health Study. Maturitas 1991; 13: 65–79
25. MacGregor EA. Menstruation, sex hormones, and migraine. Neurol Clin 1997; 15: 125–41
26. Fettes I. Migraine in the menopause. Neurology 1999; 53: S29–S33
27. MacGregor A. Gynecological aspects of migraine. Rev Contemp Pharmacother 2000; 11: 75–90
28. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC, Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993; 33: 385–389
29. MacGregor EA, Barnes D. Migraine in a specialist menopause clinic. Climacteric 1999; 2: 218–23
30. Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH. Migraine prevalence during menopausal transition. Headache 2003; 43: 470–478
31. Mattsson P. Hormonal factors in migraine: a population-based study of women aged 40 to 74 years. Headache 2003; 43: 27–35
32. Neri I, Granella F, Nappi R, Manzoni GC, Facchinetti F, Genazzani AR, Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas 1993; 17: 31–37
33. Oldenhave A, Jaszmann LJ, Everaerd WT, Haspels AA. Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age. Am J Obstet Gynecol 1993; 168: 765–71
34. Loder E, Rizzoli P, Golub J. Hormonal management of migraine associated with menses and the menopause: a clinical review. Headache 2007; 47: 329–40
35. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. 2nd edn; Cephalalgia 2004; Supplement 1: 9–160
36. Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis – part I. Headache 2006; 46: 3–23
37. Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis – part 2. Headache 2006; 46: 365–86
38. Genazzani AR, Stomati M, Morittu A,, et al. Progesterone, progestagens and the central nervous system. Hum Reprod 2000; 15: S14–S27
39. Modena MG, Sismondi P, Mueck AO,, et al. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. Maturitas 2005; 52: 1–10
40. MacGregor EA. Migraine and the menopause. J Br Menopause Soc 2006; 12: 104–108
41. de Lignieres B, MacGregor EA. Risks and benefits of hormone replacement therapy. Cephalalgia 2000; 20: 164–169
42. Silberstein SD, Merriam GR. Estrogens, progestins and headache. Neurology 1991; 41: 786–93
43. Panay N, Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997; 3: 159–71
44. MacGregor EA. Effect of oral and transdermal estrogen replacement on migraine. Cephalalgia 1999; 19: 124–125
45. MacGregor EA. Estrogen replacement and migraine aura. Headache 1999; 39: 674–678
46. Hodson J, Thompson J, Al-Azzawi F. Headache at menopause and in hormone replacement therapy users. Climacteric 2000; 3: 119–24
47. Small R, Friedman GD, Ettinger B. Concomitant medication use in postmenopausal women using estrogen therapy. Menopause 2001; 8: 120–126
48. Misakian AL, Langer RD, Bensenor IM,, et al. Postmenopausal hormone therapy and migraine headache. J Womens Health 2003; 12: 1027–36
49. Aegidius KL, Zwart JA, Hagen K, Schei B, Stovner LJ. Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT Study. Eur J Neurol 2007; 14: 73–78
50. Greendale GA, Reboussin BA, Hogan P,, et al. Symptom relief and side effects of postmenopausal hormones: Results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 1998; 92: 982–988
51. Lichten EM, Lichten JB, Whitty A, Pieper D. The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test. Headache 1996; 36: 367–71
52. Nappi G, Jensen R, Nappi RE, Sances G, Torelli P, Olesen J. Diaries and calendars for migraine. A review. Cephalalgia 2006; 26: 905–16
53. Nappi RE, Cagnacci A, Granella F, Piccinini F, Polatti F, Facchinetti F. Course of primary headaches during hormone replacement therapy. Maturitas 2001; 38: 157–63
54. Bono G, Neri I, Granella F, Genazzani AR, Facchinetti F. Factors associated with pain complaints in a clinical sample of postmenopausal women. J Psychosom Obstet Gynecol 1995; 16: 117–21
55. Facchinetti F, Nappi RE, Tirelli A, Polatti F, Nappi G, Sances G. Hormone supplementation differently affects migraine in postmenopausal women. Headache 2002; 42: 924–929
56. Nand SL, Webster MA, Baber R, Heller GZ. Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study Group. Climacteric 1998; 1: 211–218
57. Nappi RE, Sances G, Sommacal A,, et al. Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches. Menopause 2006; 13: 818–25
58. MacGregor EA. Headache and hormone replacement therapy in the postmenopausal woman. Curr Treat Options Neurol 2009; 11: 10–17